Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial.

Autoria(s): Rabaglio, M; Sun, Z; Price, K; Castiglione-Gertsch, Monica; Hawle, H; Thürlimann, Beat; Mouridsen, Henning; Campone, M.; Forbes, John F; Paridaens, R J; Colleoni, Marco Angelo; Pienkowski, Tadeusz; Nogaret, Jean-Marie; Láng, I; Smith, Ian; Gelber, R D; Goldhirsch, Aron; Coates, Alan; BIG 1-98 Collaborative and International Breast Cancer Study Groups
Data(s)

01/09/2009
Resumo

To compare the incidence and timing of bone fractures in postmenopausal women treated with 5 years of adjuvant tamoxifen or letrozole for endocrine-responsive early breast cancer in the Breast International Group (BIG) 1-98 trial.

Clinical Trial, Phase III

Journal Article

Randomized Controlled Trial

Research Support, Non-U.S. Gov't

SCOPUS: ar.j

info:eu-repo/semantics/published
Formato

1 full-text file(s): application/pdf
Identificador

uri/info:doi/10.1093/annonc/mdp033

uri/info:pii/mdp033

uri/info:pmid/19474112

uri/info:pmcid/PMC2731016

https://dipot.ulb.ac.be/dspace/bitstream/2013/119811/1/PMC2731016.pdf

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/119811
Idioma(s)

en
Direitos

1 full-text file(s): info:eu-repo/semantics/closedAccess
Fonte

Annals of oncology, 20 (9
Palavras-Chave #Cancérologie #Aged #Antineoplastic Agents -- therapeutic use #Breast Neoplasms -- complications -- drug therapy #Double-Blind Method #Female #Fractures, Bone -- epidemiology -- etiology #Humans #Incidence #Middle Aged #Nitriles -- therapeutic use #Postmenopause #Risk Factors #Tamoxifen -- therapeutic use #Triazoles -- therapeutic use
Tipo

info:eu-repo/semantics/article

info:ulb-repo/semantics/articlePeerReview

info:ulb-repo/semantics/openurl/article
Acesso ao item digital